Cargando…
Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252925/ https://www.ncbi.nlm.nih.gov/pubmed/33504141 http://dx.doi.org/10.3324/haematol.2020.270298 |
| _version_ | 1783717399797694464 |
|---|---|
| author | Kittai, Adam S. Best, Scott Thurlow, Bria Lam, Vi Hashiguchi, Taylor Goodyear, Shaun Persky, Daniel O. Okada, Craig Park, Byung Spurgeon, Stephen E. Danilov, Alexey V. |
| author_facet | Kittai, Adam S. Best, Scott Thurlow, Bria Lam, Vi Hashiguchi, Taylor Goodyear, Shaun Persky, Daniel O. Okada, Craig Park, Byung Spurgeon, Stephen E. Danilov, Alexey V. |
| author_sort | Kittai, Adam S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8252925 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82529252021-07-14 Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies Kittai, Adam S. Best, Scott Thurlow, Bria Lam, Vi Hashiguchi, Taylor Goodyear, Shaun Persky, Daniel O. Okada, Craig Park, Byung Spurgeon, Stephen E. Danilov, Alexey V. Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-01-28 /pmc/articles/PMC8252925/ /pubmed/33504141 http://dx.doi.org/10.3324/haematol.2020.270298 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Kittai, Adam S. Best, Scott Thurlow, Bria Lam, Vi Hashiguchi, Taylor Goodyear, Shaun Persky, Daniel O. Okada, Craig Park, Byung Spurgeon, Stephen E. Danilov, Alexey V. Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies |
| title | Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies |
| title_full | Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies |
| title_fullStr | Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies |
| title_full_unstemmed | Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies |
| title_short | Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies |
| title_sort | entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and b-cell malignancies |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252925/ https://www.ncbi.nlm.nih.gov/pubmed/33504141 http://dx.doi.org/10.3324/haematol.2020.270298 |
| work_keys_str_mv | AT kittaiadams entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT bestscott entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT thurlowbria entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT lamvi entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT hashiguchitaylor entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT goodyearshaun entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT perskydanielo entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT okadacraig entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT parkbyung entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT spurgeonstephene entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies AT danilovalexeyv entospletinibandobinutuzumabinpatientswithrelapsedrefractorychroniclymphocyticleukemiaandbcellmalignancies |